Growth Metrics

Arrowhead Pharmaceuticals (ARWR) Other Operating Expenses: 2010-2016

Historic Other Operating Expenses for Arrowhead Pharmaceuticals (ARWR) over the last 7 years, with Dec 2016 value amounting to $7.9 million.

  • Arrowhead Pharmaceuticals' Other Operating Expenses rose 11.16% to $7.9 million in Q4 2016 from the same period last year, while for Dec 2016 it was -$3.0 million, marking a year-over-year decrease of 107.06%. This contributed to the annual value of -$3.8 million for FY2016, which is 109.26% down from last year.
  • As of Q4 2016, Arrowhead Pharmaceuticals' Other Operating Expenses stood at $7.9 million, which was up 130.26% from -$26.1 million recorded in Q3 2016.
  • In the past 5 years, Arrowhead Pharmaceuticals' Other Operating Expenses registered a high of $47.4 million during Q3 2012, and its lowest value of -$26.1 million during Q3 2016.
  • Over the past 3 years, Arrowhead Pharmaceuticals' median Other Operating Expenses value was $7.1 million (recorded in 2015), while the average stood at $5.0 million.
  • As far as peak fluctuations go, Arrowhead Pharmaceuticals' Other Operating Expenses spiked by 6,618.65% in 2012, and later plummeted by 307.38% in 2016.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Other Operating Expenses (Quarterly) stood at $2.5 million in 2012, then rose by 21.48% to $3.0 million in 2013, then soared by 81.47% to $5.5 million in 2014, then skyrocketed by 30.04% to $7.1 million in 2015, then increased by 11.16% to $7.9 million in 2016.
  • Its Other Operating Expenses was $7.9 million in Q4 2016, compared to -$26.1 million in Q3 2016 and $7.7 million in Q2 2016.